# Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery

> **NCT04625764** · NA · TERMINATED · sponsor: **CytoSorbents Europe GmbH** · enrollment: 6 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **PROCEDURE:** Blood sampling and analysis

## Key facts

- **NCT ID:** NCT04625764
- **Lead sponsor:** CytoSorbents Europe GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-23
- **Primary completion:** 2021-10-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to Corona pandemic, planned ammount of enrolled patient could not be reached, protocol section "Early termination of the study" - criterion "Difficulties in recruiting patients" is fully met-\>recruitment period will not be extended
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04625764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04625764, "Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04625764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*